Early isovolaemic haemofiltration in oliguric patients with septic shock
- 18 November 2005
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 32 (1) , 80-86
- https://doi.org/10.1007/s00134-005-2815-x
Abstract
Objective: To evaluate the effects of early short-term, isovolaemic haemofiltration at 45 ml/kg/h on physiological and clinical outcomes in patients with septic shock. Design: Retrospective study before and after a change of unit protocol (study period 8 years). Setting: Intensive care unit of metropolitan hospital. Patients: Eighty patients with septic shock. Interventions: Introduction of a new septic shock protocol based on early isovolaemic haemofiltration (EIHF). In the pre-EIHF period (before), 40 patients received conventional supportive therapy. In the post-EIHF period (after), 40 patients received EIHF at 45 ml/kg/h of plasma-water exchange over 6 h followed by conventional continuous venovenous haemofiltration (CVVH). Anticoagulation policy remained unchanged. Measurements and main results: The two groups were comparable for age, gender and baseline APACHE II score. Delivered haemofiltration dose was above 85% of prescription in all patients. PaO2/FiO2 ratio increased from 117±59 to 240±50 in EIHF, while it changed from 125±55 to 160±50 in the control group ( p p p p p p Conclusions: In patients with septic shock, EIHF was associated with improved gas exchange, haemodynamics, greater likelihood of successful weaning and greater 28-day survival compared with conventional therapy.Keywords
This publication has 32 references indexed in Scilit:
- Extracorporeal Therapies in Non-Renal Disease: Treatment of Sepsis and the Peak Concentration HypothesisBlood Purification, 2004
- Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitisKidney International, 2002
- Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trialCritical Care Medicine, 2002
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Continuous plasmafiltration in sepsis syndromeCritical Care Medicine, 1999
- Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeabilityKidney International, 1999
- Treating Patients with Severe SepsisNew England Journal of Medicine, 1999
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Acute renal failure in intensive care units--Causes, outcome, and prognostic factors of hospital mortalityCritical Care Medicine, 1996
- APACHE IICritical Care Medicine, 1985